SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612) (BCYC) — May 20, 2019

BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612)
Date: May 20, 2019 · CIK: 0001761612 · Accession: 0001104659-19-030545

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-231076

Date
May 20, 2019
Author
Managing Director
Form
CORRESP
Company
BICYCLE THERAPEUTICS PLC (BCYC) (CIK 0001761612)

Letter

Via EDGAR Submission Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549-7010 Attn: Chris Edwards and Liz Walsh Re: Bicycle Therapeutics Ltd. Registration Statement on Form S-1, as amended (File No. 333-231076) Request for Acceleration of Effective Date

Dear Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as the representatives of the several underwriters, hereby join in the request of Bicycle Therapeutics Limited (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 p.m. Eastern Time on May 22, 2019, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we, as the representatives of the several underwriters, wish to advise you that between May 13, 2019 through the date hereof we and the other prospective underwriters have distributed approximately 3,070 copies of the Company’s Preliminary Prospectus dated May 13, 2019 to prospective underwriters, dealers, institutional investors and others.

We, the undersigned, as the representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

(signature page follows)

Very truly yours,
GOLDMAN SACHS & CO. LLC

Show Raw Text
CORRESP
1
filename1.htm

Goldman Sachs & Co. LLC

Jefferies LLC

Piper Jaffray & Co.

As representatives of the several Underwriters
 named in Schedule I of the Underwriting Agreement

c/o Goldman Sachs & Co. LLC

200 West Street

New York, NY  10282

c/o Jefferies LLC

520 Madison Avenue

New York, NY 10022

c/o Piper Jaffray & Co.

345 Park Avenue, 12th Floor

New York, NY 10154

May 20, 2019

Via EDGAR Submission

Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, DC 20549-7010

Attn: Chris Edwards and Liz Walsh

Re:

Bicycle   Therapeutics Ltd.
    Registration Statement on Form S-1, as amended (File   No. 333-231076)
   Request for Acceleration of Effective Date

Dear Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as the representatives of the several underwriters, hereby join in the request of Bicycle Therapeutics Limited (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 p.m. Eastern Time on May 22, 2019, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we, as the representatives of the several underwriters, wish to advise you that between May 13, 2019 through the date hereof we and the other prospective underwriters have distributed approximately 3,070 copies of the Company’s Preliminary Prospectus dated May 13, 2019 to prospective underwriters, dealers, institutional investors and others.

We, the undersigned, as the representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

(signature page follows)

2

Very   truly yours,

GOLDMAN   SACHS & CO. LLC

JEFFERIES   LLC

PIPER   JAFFRAY & CO.

As   representatives of the several underwriters listed in Schedule I to the   Underwriting Agreement

GOLDMAN   SACHS & CO. LLC

By:

/s/   Elizabeth Wood

Name:

Elizabeth   Wood

Title:

Managing Director

JEFFERIES   LLC

By:

/s/   Charles Glazer

Name:

Charles   Glazer

Title:

Managing Director

PIPER   JAFFRAY & CO.

By:

/s/   Chad E. Huber

Name:

Chad   E. Huber

Title:

Managing Director

(Signature Page to Acceleration Request Letter)